Zhang HT, Peng R, Chen S, Shen A, Zhao L, Tang W, Wang XH, Li ZY, Zha ZG, Yi M, et al. Versatile Nano-PROTAC-Induced Epigenetic Reader degradation for efficient Lung Cancer Therapy. Adv Sci (Weinh). 2022;9:e2202039.

Article  PubMed  Google Scholar 

Qiu H, Cao S, Xu R. Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020. Cancer Commun (Lond). 2021;41:1037–48.

Article  PubMed  Google Scholar 

Zhang LX, Gao J, Long X, Zhang PF, Yang X, Zhu SQ, Pei X, Qiu BQ, Chen SW, Lu F, et al. The circular RNA circHMGB2 drives immunosuppression and anti-PD-1 resistance in lung adenocarcinomas and squamous cell carcinomas via the miR-181a-5p/CARM1 axis. Mol Cancer. 2022;21:110.

Article  PubMed  PubMed Central  Google Scholar 

Wang S, Gao A, Liu J, Sun Y. First-line therapy for advanced non-small cell lung cancer with activating EGFR mutation: is combined EGFR-TKIs and chemotherapy a better choice? Cancer Chemother Pharmacol. 2018;81:443–53.

Article  CAS  PubMed  Google Scholar 

Suda K, Rivard CJ, Mitsudomi T, Hirsch FR. Overcoming resistance to EGFR tyrosine kinase inhibitors in lung cancer, focusing on non-T790M mechanisms. Expert Rev Anticancer Ther. 2017;17:779–86.

Article  CAS  PubMed  Google Scholar 

Lei HM, Zhang KR, Wang CH, Wang Y, Zhuang GL, Lu LM, Zhang J, Shen Y, Chen HZ, Zhu L. Aldehyde dehydrogenase 1A1 confers erlotinib resistance via facilitating the reactive oxygen species-reactive carbonyl species metabolic pathway in lung adenocarcinomas. Theranostics. 2019;9:7122–39.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jacobsen K, Bertran-Alamillo J, Molina MA, Teixido C, Karachaliou N, Pedersen MH, Castellvi J, Garzon M, Codony-Servat C, Codony-Servat J, et al. Convergent akt activation drives acquired EGFR inhibitor resistance in lung cancer. Nat Commun. 2017;8:410.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Zhang N, Han Q, Lu W, Wang L, Yang D, Zheng M, Zhang Z, Liu H, Lee TH, et al. Pin1 inhibition reverses the acquired resistance of human hepatocellular carcinoma cells to Regorafenib via the Gli1/Snail/E-cadherin pathway. Cancer Lett. 2019;444:82–93.

Article  CAS  PubMed  Google Scholar 

Yuan K, Xie K, Lan T, Xu L, Chen X, Li X, Liao M, Li J, Huang J, Zeng Y, et al. TXNDC12 promotes EMT and metastasis of hepatocellular carcinoma cells via activation of beta-catenin. Cell Death Differ. 2020;27:1355–68.

Article  CAS  PubMed  Google Scholar 

Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, Thiery JP. Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients. EMBO Mol Med. 2014;6:1279–93.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hatami R, Sieuwerts AM, Izadmehr S, Yao Z, Qiao RF, Papa L, Look MP, Smid M, Ohlssen J, Levine AC, et al. KLF6-SV1 drives breast cancer metastasis and is associated with poor survival. Sci Transl Med. 2013;5:169ra12.

Article  PubMed  PubMed Central  Google Scholar 

Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Singh M, Yelle N, Venugopal C, Singh SK. EMT: mechanisms and therapeutic implications. Pharmacol Ther. 2018;182:80–94.

Article  CAS  PubMed  Google Scholar 

Suda K, Tomizawa K, Fujii M, Murakami H, Osada H, Maehara Y, Yatabe Y, Sekido Y, Mitsudomi T. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib. J Thorac Oncol. 2011;6:1152–61.

Article  PubMed  Google Scholar 

Witta SE, Gemmill RM, Hirsch FR, Coldren CD, Hedman K, Ravdel L, Helfrich B, Dziadziuszko R, Chan DC, Sugita M, et al. Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines. Cancer Res. 2006;66:944–50.

Article  CAS  PubMed  Google Scholar 

Sequist LV, Waltman BA, Dias-Santagata D, Digumarthy S, Turke AB, Fidias P, Bergethon K, Shaw AT, Gettinger S, Cosper AK, et al. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors. Sci Transl Med. 2011;3:75ra26.

Article  PubMed  PubMed Central  Google Scholar 

Singh A, Greninger P, Rhodes D, Koopman L, Violette S, Bardeesy N, Settleman J. A gene expression signature associated with K-Ras addiction reveals regulators of EMT and tumor cell survival. Cancer Cell. 2009;15:489–500.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Carretero J, Shimamura T, Rikova K, Jackson AL, Wilkerson MD, Borgman CL, Buttarazzi MS, Sanofsky BA, McNamara KL, Brandstetter KA, et al. Integrative genomic and proteomic analyses identify targets for Lkb1-deficient metastatic lung tumors. Cancer Cell. 2010;17:547–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kondratyeva L, Chernov I, Kopantzev E, Didych D, Kuzmich A, Alekseenko I, Kostrov S, Sverdlov E. Pancreatic lineage specifier PDX1 increases adhesion and decreases motility of Cancer cells. Cancers (Basel). 2021; 13.

Soucheray M, Capelletti M, Pulido I, Kuang Y, Paweletz CP, Becker JH, Kikuchi E, Xu C, Patel TB, Al-Shahrour F, et al. Intratumoral Heterogeneity in EGFR-Mutant NSCLC results in Divergent Resistance mechanisms in response to EGFR tyrosine kinase inhibition. Cancer Res. 2015;75:4372–83.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guo Y, Peng D, Zhou J, Lin S, Wang C, Ning W, Xu H, Deng W, Xue Y. iEKPD 2.0: an update with rich annotations for eukaryotic protein kinases, protein phosphatases and proteins containing phosphoprotein-binding domains. Nucleic Acids Res. 2019;47:D344–50.

Article  CAS  PubMed  Google Scholar 

Zhu Y, Cang S, Chen B, Gu Y, Jiang M, Yan J, Shao F, Huang X. Patient stratification of Clear Cell Renal Cell Carcinoma using the global transcription factor activity Landscape Derived from RNA-Seq Data. Front Oncol. 2020;10:526577.

Article  PubMed  PubMed Central  Google Scholar 

Nersisyan L, Hopp L, Loeffler-Wirth H, Galle J, Loeffler M, Arakelyan A, Binder H. Telomere Length Maintenance and its transcriptional regulation in Lynch Syndrome and sporadic colorectal carcinoma. Front Oncol. 2019;9:1172.

Article  PubMed  PubMed Central  Google Scholar 

Tran AN, Walker K, Harrison DG, Chen W, Mobley J, Hocevar L, Hackney JR, Sedaka RS, Pollock JS, Goldberg MS, et al. Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance. Neuro Oncol. 2018;20:1055–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xie Y, Liu Y, Li Q, Chen J. Polo-like kinase 2 promotes chemoresistance and predicts limited survival benefit from adjuvant chemotherapy in colorectal cancer. Int J Oncol. 2018;52:1401–14.

CAS  PubMed  PubMed Central  Google Scholar 

Dong B, Wu C, Huang L, Qi Y. Macrophage-related SPP1 as a potential biomarker for early Lymph Node Metastasis in Lung Adenocarcinoma. Front Cell Dev Biol. 2021;9:739358.

Article  PubMed  PubMed Central  Google Scholar 

Gu X, Huang X, Zhang X, Wang C. Development and validation of a DNA methylation-related classifier of circulating Tumour cells to Predict Prognosis and to provide a therapeutic strategy in Lung Adenocarcinoma. Int J Biol Sci. 2022;18:4984–5000.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yuan H, Yan M, Zhang G, Liu W, Deng C, Liao G, Xu L, Luo T, Yan H, Long Z, et al. CancerSEA: a cancer single-cell state atlas. Nucleic Acids Res. 2019;47:D900–8.

Article  CAS  PubMed  Google Scholar 

Liu CJ, Hu FF, Xia MX, Han L, Zhang Q, Guo AY. GSCALite: a web server for gene set cancer analysis. Bioinformatics. 2018;34:3771–2.

Article  CAS